Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune ...

Older adults with advanced kidney disease are often motivated to receive a transplant but may face emotional and psychosocial ...

All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a successful anticancer immune response.

Jaslok Hospital & Research Centre has made history by successfully performing India’s first kidney transplant on a patient ...

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

Since the 1990s, a race-based method for assessing kidney function placed many Black patients lower on the transplant ...

We described three cases of renal transplant patients with concomitant impaired ... A 50-year-old male was diagnosed with IgA nephropathy in 2012 and underwent kidney transplantation in January 2023.

Her kidneys were only functioning at four per cent and – without a transplant – her chances of survival were extremely poor. Because the average waiting time for a kidney transplant in the UK ...

Background: National and international clinical guidelines do not consistently recommend treating nondiabetic proteinuric patients with advanced renal disease with an angiotensin-converting enzyme ...

Introduction: The Swiss allocation system for kidney transplantation has evolved over time to balance medical urgency, immunological compatibility, and waiting time. Since the introduction of the ...